AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Report Publication Announcement Jun 5, 2020

3714_rns_2020-06-05_8597ba7a-1378-42f4-9e0a-440e3e86984a.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Photocure to present at the ABG Sundal Collier Virtual Oncology Seminar

Photocure to present at the ABG Sundal Collier Virtual Oncology Seminar

Oslo, Norway, June 5, 2020 - Photocure ASA (OSE: PHO) will be presenting at the

annual ABG Sundal Collier Virtual Oncology Seminar on June 10. This event

features Norwegian companies in the oncology space.

The presentation is scheduled at 11:05 am CET and will be held remotely by Dan

Schneider, President and CEO of Photocure ASA.

The presentation will be posted on www.Photocure.com prior to the presentation.

Company contacts:

Erik Dahl

Chief Financial Officer

Tel: +47 450 55 000

Email: [email protected]

Media and IR enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

Email: [email protected]

About Photocure

Photocure, The Bladder Cancer Company, delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, which makes

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us

at www.photocure.com, www.hexvix.com or www.cysview.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.